ANI PHARMACEUTICALS INC·4

May 13, 4:15 PM ET

Cook Meredith 4

4 · ANI PHARMACEUTICALS INC · Filed May 13, 2026

Research Summary

AI-generated summary of this filing

Updated

ANI Pharmaceuticals (ANIP) Sr. VP Meredith Cook Sells 500 Shares

What Happened

  • Meredith Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares on 2026-05-13 in an open-market transaction at $78.16 per share, totaling $39,080. This was a sale (not a purchase) and does not by itself indicate a change in company prospects.

Key Details

  • Transaction date and price: 2026-05-13; 500 shares sold at $78.16 per share.
  • Total proceeds: $39,080.
  • Shares owned after transaction: not specified in this Form 4 filing.
  • Footnote: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025 (see footnote F1).
  • Filing timeliness: the Form 4 was filed with the SEC on 2026-05-13 (the same date as the reported transaction); no late filing is indicated.

Context

  • Trades under a 10b5-1 plan are pre-scheduled trading arrangements that can allow insiders to sell shares at set times; such sales are often routine and do not necessarily reflect the insider’s current view of the company.

Insider Transaction Report

Form 4
Period: 2026-05-13
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Transactions
  • Sale

    Common Stock

    [F1]
    2026-05-13$78.16/sh500$39,08078,390 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
Signature
/s/ Meredith W. Cook|2026-05-13

Documents

1 file
  • 4
    wk-form4_1778703326.xmlPrimary

    FORM 4